Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans

Cancer Letters

Volumn 200, Issue 1, 2003, Pages 41-47

  Van Der Woude, Hester ^a   Gliszczyńska Świgło, Anna ^a,b   Struijs, Karin ^a   Smeets, Astrid ^a   Alink, Gerrit M ^a   Rietjens, Ivonne M C M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b POZNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Poland)

Author keywords

Ascorbic acid; Biphasic effect; Proliferation; Quercetin; Solubility; Stability

Indexed keywords

QUERCETIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0141863169     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00412-9     Document Type: Article

References (34)

1. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33:1995;1061-1080.
2. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer. 20:1993;21-29.
3. S. Budavari (1996), Merck & Co., Whitehouse Station (NJ).
4. Duthie S.J., Johnson W., Dobson V.L. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mut. Res. 390:1997;141-151.
5. Moridani M.Y., Galati G., O'Brien P.J. Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem. Biol. Interact. 139:2002;251-264.
6. Makris D.P., Rossiter J.T. Heat-induced, metal-catalyzed oxidative degradation of quercetin and rutin (quercetin-3-O-rhamnosylglucoside) in aqueous model systems. J. Agric. Food Chem. 48:2000;3830-3838.
7. Balabhadrapathruni S., Thomas T.J., Yurkow E.J., Amenta P.S., Thomas T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol. Rep. 7:2000;3-12.
8. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110:1996;41-48.
9. Agullo G., Gamet-Peyastre L., Fernandez Y., Anciaux N., Demigné C., Rémésy C. Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett. 105:1996;61-70.
10. Ranelletti F.O., Ricci R., Larocca L.M., Maggiano N., Capelli A., Scambia G., Benedetti-Panici P., Mancuso S., Rumi C., Piantelli M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer. 50:1992;486-492.
11. Boersma M.G., van der Woude H., Bogaards J., Boeren S., Vervoort J., Cnubben N.H., van Iersel M.L., van Bladeren P.J., Rietjens I.M.C.M. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 15:2002;662-670.
12. Mitchell D.B., Santone K.S., Acosta D. Evaluation of cytotoxicity in cultured cells by enzyme leakage. J. Tiss. Cult. Meth. 6:1980;113-116.
13. Boulton D.W., Walle U.K., Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol. 50:1998;243-249.
14. Vrijsen R., Everaert L., Boeyé A. Antiviral activity of flavones and potentiation by ascorbate. J. Gen. Virol. 69:1988;1749-1751.
15. Kandaswami C., Perkins E., Sononiuk D.S., Drzewiecki G., Middleton E. Jr. Ascorbic acid-enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro. Anticancer Drugs. 4:1993;91-96.
16. Scambia G., et al. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br. J. Cancer. 62:1990;942-946.
17. Boulton D.W., Walle K.U., Walle T. Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. J. Pharm. Pharmacol. 51:1999;353-359.
18. Makris D.P., Rossiter J.T. Comparison of quercetin and a non-orthohydroxy flavonol as antioxidants by competing in vitro oxidation reactions. J. Agric. Food Chem. 49:2001;3370-3377.
19. Matter W.F., Brown R.F., Vlahos C.J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun. 186:1992;624-631.
20. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 53:1997;1649-1657.
21. Markaverich B.M., Roberts R.R., Alejandro M.A., Johnson G.A., Middleditch B.S., Clark J.H. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem. 30:1988;71-78.
22. Markaverich B.M., Roberts R.R., Alejandro M.A., Clark J.H. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res. 44:1984;1515-1519.
23. Scambia G., Ranelletti F.O., Benedetti Panici P., Piantelli M., Rumi C., Battaglia F., Larocca L.M., Capelli A., Mancuso S. Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids. Int. J. Cancer. 46:1990;1112-1116.
24. Elattar T.M., Virji A.S. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 20:2000;1733-1738.
25. Zava D.T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer. 27:1997;31-40.
26. Maggiolini M., Statti G., Vivacqua A., Gabriele S., Rago V., Loizzo M., Menichini F., Amdo S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 82:2002;315-322.
27. Arai N., Strom A., Rafter J.J., Gustafsson J.A. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem. Biophys. Res. Commun. 270:2000;425-431.
28. Maggiolini M., Bonofiglio D., Marsico S., Panno M.L., Cenni B., Picard D., Ando S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 60:2001;595-602.
29. Stebbing A.R. Hormesis - the stimulation of growth by low levels of inhibitors. Sci. Total Environ. 22:1982;213-234.
30. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 20:1996;933-956.
31. Areias F.M., Rego A.C., Oliveira C.R., Seabra R.M. Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. Biochem. Pharmacol. 62:2001;111-118.
32. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaité E., Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radical Biol. Med. 26:1999;107-116.
33. Hollman P.C., vd Gaag M., Mengelers M.J., van Trijp J.M., de Vries J.H., Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21:1996;703-707.
34. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., Parantainen J., Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56:2000;545-553.